During the past decade, Hammoud Hospital University Medical Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 10 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hammoud Hospital University Medical Center" #1 sponsor was "Shire" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "AB Science" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hammoud Hospital University Medical Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator and "Phoenix Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hammoud Hospital University Medical Center" are "Crohn's Disease" (6 trials), "Ulcerative Colitis" (3 trials), "Sickle Cell Disease" (2 trials), "Venous Thromboembolism" (2 trials) and "Acute Diarrhoea" (1 trials). Many other conditions were trialed in "Hammoud Hospital University Medical Center" in a lesser frequency.

Most popular intervention types in "Hammoud Hospital University Medical Center" are "Drug" (21 trials), "Other" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ontamalimab" (4 trials), "Gemcitabine" (2 trials), "Masitinib" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hammoud Hospital University Medical Center" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hammoud Hospital University Medical Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hammoud Hospital University Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hammoud Hospital University Medical Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".